VistaGen Therapeutics Inc. Common Stock is a biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative therapies for mental health disorders. With a strong focus on depression and other central nervous system disorders, VistaGen Therapeutics aims to improve the lives of patients through groundbreaking treatments and advancements in the field.
